Dr. Nathan Pennell received his Ph.D. in neuroscience in 1998 and his M.D. in 2002 from the University of Florida College of Medicine in Gainesville, FL. He then moved to Boston to do his internal medicine internship and residency training at Brigham & Women’s Hospital, and completed his medical oncology fellowship at the Dana Farber Cancer Institute, also in Boston. While there, he developed an expertise in lung cancer, mesothelioma, and thyroid cancer. He moved to the friendly midwest in 2008 to continue with this focus at the Taussig Cancer Institute at the Cleveland Clinic.
Dr. Pennell specializes in the treatment of thoracic malignancies with a focus on lung cancer. His research interests include clinical trials using novel therapies, with a goal of facilitating the movement of new treatments from the laboratory to the clinic. GRACE is pleased to welcome Dr. Pennell as a faculty member.
None
From the GRACE Archives - Originally Published August 26, 2009 | By Dr Pennell
OK, I hope you all aren’t bored to tears by this topic by now, given two related posts in April and again earlier this month describing the “broken” clinical trials system and the challenges to performing clinical research in the current environment. However, I thought this would be a good follow up post to let all of you know that the laughably obstructionist policies in place that prevent timely processing of clinical trials are being recognized, and that something is being done to fix it.
From the GRACE Archives - Originally Published April 11, 2009 | By Dr Pennell
Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses new options in acquired resistance for ALK positive non-small cell lung cancer (NSCLC).
Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses the role for immunotherapy in patients with a driver mutation.
Forum Discussions
There is not a ton of info available for Cholangiocarcinoma, so seeing information come up with new developments is always exciting. In this video, Rachna Shroff MD, chief of Gastrointestinal Medical
Hi all -- share your cancer journey here and connect with others. Cancer.gov has a good general description of Cholangiocarcinoma. This rare disease has support information and programs that can be
Keep your eye out for new Head and Neck information soon!
Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder. Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the
The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!
Comments
I agree that not all docs are good communicators! Remember they are people just like us, filling a
Our friend and past participant Melinda Bachini shared with us some information on her clinical
It is so good to hear from you, and my sentiments are the same as Janine's. You are definitely why
You may find our clinical trial page helpful, also. https://cancergrace.org/find-clinical-trials.